A-253 SMAD/TGFbeta Reporter (Luc) stable cell line
A-253 SMAD/TGFbeta Reporter (Luc) cells are derived from the human salivary cancer A-253 cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. A-253 cells have been used in cancer research and drug development. A-253 SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGF?/SMAD signaling pathway.
Product Specifications
No additional specifications available.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC741081-500 1x 500 µL
CD45RO (190-2F2.5), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470965-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741492-500 1x 500 µL
PAX8 (Renal Cell Marker) (PAX8/1492), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details